These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1046 related articles for article (PubMed ID: 3394269)

  • 1. [Pharmacokinetics of nitrosomethylurea in oncologic patients].
    Korman DB; Kim OA; Gor'kov VA
    Vopr Onkol; 1988; 34(6):694-9. PubMed ID: 3394269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of age and chemotherapy on gentamicin pharmacokinetics and dosing in pediatric oncology patients.
    Ho KK; Bryson SM; Thiessen JJ; Greenberg ML; Einarson TR; Leson CL
    Pharmacotherapy; 1995; 15(6):754-64. PubMed ID: 8602384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nitrosomethylurea in the treatment of patients with disseminated cutaneous melanoma].
    Dement'eva NP; Koroleva LA
    Vopr Onkol; 1984; 30(7):51-4. PubMed ID: 6464402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization and prognosis of the effectiveness of using nitrosomethylurea for treating malignant tumor patients based on pharmacokinetic parameters].
    Konradov AA; Kutyrkin VA; Kim VA; Korman DB; Emanuél' NM
    Izv Akad Nauk SSSR Biol; 1985; (1):16-24. PubMed ID: 3980847
    [No Abstract]   [Full Text] [Related]  

  • 5. Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
    Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Pandey RK; Tsuchida T; Dougherty TJ
    Cancer Res; 2003 Apr; 63(8):1806-13. PubMed ID: 12702566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma.
    Joerger M; Huitema AD; Meenhorst PL; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2005 May; 55(5):488-96. PubMed ID: 15726371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical pharmacokinetic trial of intravenous injection of recombinant human lymphotoxin-alpha derivative].
    Li S; Wang FH; Liao H; Li YH; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Dec; 25(12):1524-8. PubMed ID: 17166379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between the effects of diltiazem and isosorbide dinitrate on digoxin pharmacodynamics and kinetics in the treatment of patients with chronic ischemic heart failure.
    Mahgoub AA; El-Medany AH; Abdulatif AS
    Saudi Med J; 2002 Jun; 23(6):725-31. PubMed ID: 12070557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and urinary excretion of vincristine sulfate liposomes injection in metastatic melanoma patients.
    Bedikian AY; Vardeleon A; Smith T; Campbell S; Namdari R
    J Clin Pharmacol; 2006 Jul; 46(7):727-37. PubMed ID: 16809798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic evaluation of linezolid in patients with major thermal injuries.
    Lovering AM; Le Floch R; Hovsepian L; Stephanazzi J; Bret P; Birraux G; Vinsonneau C
    J Antimicrob Chemother; 2009 Mar; 63(3):553-9. PubMed ID: 19153078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients.
    Latz JE; Chaudhary A; Ghosh A; Johnson RD
    Cancer Chemother Pharmacol; 2006 Apr; 57(4):401-11. PubMed ID: 16322991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of body surface area as a determinant of paclitaxel pharmacokinetics and pharmacodynamics in women with solid tumors: Cancer and Leukemia Group B Study 9763.
    Miller AA; Rosner GL; Egorin MJ; Hollis D; Lichtman SM; Ratain MJ
    Clin Cancer Res; 2004 Dec; 10(24):8325-31. PubMed ID: 15623609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modern problems of clinical chemotherapy of malignant tumours.
    Perevodchikova NI; Bychkov MB
    Arch Geschwulstforsch; 1980; 50(7):657-63. PubMed ID: 6263209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of interleukin-12 with lung cancer and malignant lymphoma undergoing autologous peripheral blood stem cell transplantation.
    Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Yamaguchi K; Fukuhara S
    J Cancer Res Clin Oncol; 2002 Jan; 128(1):29-36. PubMed ID: 11862469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hepatic impairment on the pharmacokinetics of atomoxetine and its metabolites.
    Chalon SA; Desager JP; Desante KA; Frye RF; Witcher J; Long AJ; Sauer JM; Golnez JL; Smith BP; Thomasson HR; Horsmans Y
    Clin Pharmacol Ther; 2003 Mar; 73(3):178-91. PubMed ID: 12621383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereoselective pharmacokinetics of L-buthionine SR-sulfoximine in patients with cancer.
    Lacreta FP; Brennan JM; Hamilton TC; Ozols RF; O'Dwyer PJ
    Drug Metab Dispos; 1994; 22(6):835-42. PubMed ID: 7895599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etoposide pharmacokinetics in children: the development and prospective validation of a dosing equation.
    Lowis SP; Pearson AD; Newell DR; Cole M
    Cancer Res; 1993 Oct; 53(20):4881-9. PubMed ID: 8402676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of high-dose melphalan in adults: influence of renal function.
    Kergueris MF; Milpied N; Moreau P; Harousseau JL; Larousse C
    Anticancer Res; 1994; 14(6A):2379-82. PubMed ID: 7825976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased hepatic clearance of clindamycin in critically ill patients with sepsis.
    Mann HJ; Townsend RJ; Fuhs DW; Cerra FB
    Clin Pharm; 1987 Feb; 6(2):154-9. PubMed ID: 3665368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I and pharmacokinetic study of carboplatin and paclitaxel with a biweekly schedule in patients with advanced non-small-cell lung cancer.
    Ichiki M; Gohara R; Fujiki R; Hoashi S; Rikimaru T; Aizawa H
    Cancer Chemother Pharmacol; 2003 Jul; 52(1):67-72. PubMed ID: 12743738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.